Slow-acting insulin analogue

insulin analogue, slow-acting · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Slow-acting insulin analogue, covering 2017-01-31 to 2017-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control

See pricing